title: Psoriatic arthritis: an update.
abstract: Advances in our understanding of the pathogenesis of psoriatic arthritis and clinical aspects of the disease justify the present review. Studies have identified common inflammatory pathways related to the innate immune response, such as the IL-12/IL-23 axis, along with numerous genes that affect susceptibility to both diseases and influence phenotypic development. Interest has grown in biomarkers that can be used for early diagnosis or prognosis or to predict joint destruction and the response to treatment. Recent reports describe important differences between the effects of disease-modifying antirheumatic drugs and biologics on the process of new bone formation. Other issues that have been discussed include the need for reliable screening methods, particularly for early detection of oligoarticular arthritis, and for protocols to guide referral to specialists, especially in newly created multidisciplinary practices.
authors.affiliation: Servicio de Dermatología, Hospital de la Sant Creu i Sant Pau, Barcelona, España. Electronic address: alopezferrer@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: López-Ferrer
authors.affiliation: Servicio de Reumatología, Hospital de la Sant Creu i Sant Pau. Barcelona, España.
authors.forename: A
authors.initials: A
authors.lastname: Laiz-Alonso
mesh_terms: D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans
keywords: Artritis psoriásica; Multidisciplinar; Multidisciplinary focus; Psoriasis; Psoriatic arthritis; Tratamiento; Treatment